1 Department of Internal Medicine, Faculty of Health Sciences, University of Buea, Buea, Cameroon ; 2 Department of Internal Medicine, General Hospital Douala, Douala, Cameroon ; 3 St Elisabeth Catholic General Hospital, Cardiothoracic Centre, Shisong, Cameroon.
Cardiovasc Diagn Ther. 2014 Jun;4(3):263-6. doi: 10.3978/j.issn.2223-3652.2014.06.01.
Lutembacher syndrome (LS) is a rare cardiac clinical entity marked by the combination of an atrial septal defect (ASD) and mitral stenosis (MS). Its prognosis is influenced by several factors.
We present the case of a young adult male who presented with a 10-month history of exertional dyspnea, orthopnoea, fatigue and cough. Clinical examination revealed features suggestive of advanced congestive heart failure. Echocardiography revealed severe MS and a secundum type ASD with pulmonary hypertension. Patient died on second day of admission.
LS is a very rare condition. The outcome is better if treated before the onset of heart failure and pulmonary hypertension. However, surgical and percutaneous trans-catheter therapy is costly and not readily available in low-income settings in developing countries.
卢特巴赫综合征（LS）是一种罕见的心脏临床病症，其特征是房间隔缺损（ASD）和二尖瓣狭窄（MS）同时存在。其预后受多种因素影响。
我们报告了一例年轻成年男性病例，其病史为 10 个月的劳力性呼吸困难、端坐呼吸、疲劳和咳嗽。临床检查显示出晚期充血性心力衰竭的特征。超声心动图显示严重的 MS 和继发孔型 ASD 合并肺动脉高压。患者在入院第二天死亡。
LS 是一种非常罕见的病症。如果在心力衰竭和肺动脉高压发生之前进行治疗，预后会更好。然而，手术和经导管介入治疗费用昂贵，在发展中国家的低收入环境中并不容易获得。
